Pulmonary Clinical Trials
Delivering quality care through clinical trials
Study Phase: Phase IIb
Condition(s): Idiopathic Pulmonary Fibrosis (IPF)
A Phase IIb Study to Evaluate the Efficacy, Safety, and Tolerability of AZD8965 in Participants
with Idiopathic Pulmonary Fibrosis (IPF) (ARGiNAUT)
ClinicalTrials.gov NCT ID: NCT07652658
You can view the full clinical description on ClinicalTrials.gov.
View Full DescriptionStudy Phase: Phase III - Device
Condition(s): Chronic Obstructive Pulmonary Disease (COPD)
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD patients in the home – a multi-center randomized controlled trial
ClinicalTrials.gov NCT ID: NCT05204888
You can view the full clinical description on ClinicalTrials.gov.
View Full DescriptionStudy Phase: Registry
Condition(s): Interstitial lung disease
A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) DeciPHer-ILD
ClinicalTrials.gov NCT ID: NCT06388421
You can view the full clinical description on ClinicalTrials.gov.
View Full DescriptionTo inquire if you're eligible for a clinical trial, contact: (484) 658-5080, or click here to complete a clinical trial inquiry form.